MGM Healthcare Chennai Builds World’s Largest Intestinal Rehab & Transplant Center in Just 3 Years!

Chennai, March 26, 2026: MGM Healthcare has established the world’s largest intestinal rehabilitation and transplant program in a record three years, marking a major milestone in advanced medical care. With over 40 intestinal transplants completed so far—including 21 in 2025 alone—the program has achieved the highest annual transplant volume globally.

(Standing): Doctors from Intestinal Rehabilitation and Transplant Center; (Sitting): Successfully treated patients

Launched under the leadership of Prof. Dr. Anil Vaidya, Chair and Director of the Institute of Multi-Visceral and Abdominal Organ Transplant, the program was conceptualized following his return from the Cleveland Clinic. A highly coordinated multidisciplinary team, including Dr. Senthil Muthuraman, Dr. Venkatesh BS, Dr. Sivakumar Mahalingam, and Dr. Manoj Prabhakar, alongside intensivists and anaesthetists such as Dr. C. P. Dinesh Babu, the late Dr. Nivash Chandrashekar, and Dr. Saravanan, has driven the program’s rapid scale and success.

Press meet Youtube Video link 👇 

“Intestinal rehabilitation and transplantation is among the most complex and resource-intensive domains in medicine,” said Prof. Vaidya. “By building the world’s largest program in this field, we have positioned Chennai as a global reference point. This initiative goes beyond surgery—it represents a fully integrated ecosystem covering rehabilitation, home-based care, infection control, and long-term monitoring.”

The program reports world-class one- and three-year survival rates, often matching or exceeding leading centres in the United States and Europe. A key indicator of success has been patient independence from total parenteral nutrition (TPN)—a method of delivering nutrients intravenously. Notably, 98% of patients treated under the program are now free from TPN, reflecting true physiological recovery and significantly improved quality of life.

Beyond scale and outcomes, the initiative has expanded the frontiers of transplantation. It has led to the creation of India’s first Transplant Oncology program—and only the third globally—where intestinal transplantation is offered as a curative treatment for patients with inoperable pseudomyxoma peritonei. This marks a paradigm shift, extending transplantation into the realm of complex cancers that were previously considered untreatable in advanced stages.

At the core of this success are three defining innovations. The first is a robust home-based total parenteral nutrition (HPN) program that enables patients to receive care outside hospital settings. The second is the introduction of Dorbimex, a patented antiseptic spray used in central line care, which—combined with strict catheter, stoma, and wound protocols—has reduced infection rates to near zero. The third is the “Back to Base” critical care transport model, a first-of-its-kind initiative in India that facilitates the safe transfer of critically ill patients from cities such as Mumbai, Delhi, Agra, Kolkata, and Goa via air, road, and even train.

Prof. Vaidya emphasized that intestinal failure is a complex, system-wide condition requiring seamless coordination across nutrition, immunology, infection control, critical care, and surgery. “What we have built is not just a clinical program, but a model of how high-complexity care can be designed and scaled in India. It demonstrates that innovation in care delivery—not just technology—is key to improving outcomes, and that global leadership in advanced medicine is no longer defined by geography,” he added.

****